Dear Medicines and Healthcare Products Regulatory Agency,
A doctor has examined a vial of the J&J COVID-19 vaccine using a light microscope. She saw some non-biological structures which she could not explain. See this:
https://www.bitchute.com/video/hYztxgTU8... at 06.21, 07.24 and 08.19

Now these structures can be explained as microbubbles made from polyvinyl alcohol see
Fig 2 in:
"Controlled Morphing of Microbubbles to Beaded Nanofibers via Electrically Forced Thin Film Stretching" by Yao et al Polymers 2017, 9(7), 265
which can be downloaded at https://www.mdpi.com/2073-4360/9/7/265/htm

1. Will you confirm that microbubbles are present in the J&J COVID-19 vaccine inoculations
2. What is the purpose of these microbubble materials in the J&J COVID-19 vaccine?
3. What safety and toxicological studies have been conducted with these microbubble materials?
4. What polymers, nano particles or other related non-biological structures are present in the Pfizer BioNTech, Moderna or Oxford/AstraZeneca COVID-19 vaccines?
5. Are graphene or graphene oxide present in Pfizer BioNTech, Moderna, Oxford/AstraZeneca or J&J COVID-19 vaccines?

Yours faithfully,

Graham Crawley

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
We will respond to you as soon as possible. 
 
Please note that we may not respond if your query: 
 
• contains offensive language
• has already been answered in a previous reply to you
• is illegible
• is selling or promoting a product
• is for information only 
 
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, 
Canary Wharf, 
London 
E14 4PU
gov.uk/mhra
Stay connected 
 
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres’ Privacy Notices: MHRA,
CPRD and NIBSC. 
 
The UK has left the EU, and the transition period ends on 31 December
2020. Ourguidance and information can be accessed here.

________________________________________ From: Graham Crawley
<[FOI #800251 email]> Sent: Saturday, October 16,
2021 2:03:19 PM To: MHRA Customer Services Subject: Freedom of Information
request - Microbubble polymers in J&J COVID-19 vaccine Dear Medicines and
Healthcare Products Regulatory Agency, A doctor has examined a vial of the
J&J COVID-19 vaccine using a light microscope. She saw some non-biological
structures which she could not explain. See this:
https://eur01.safelinks.protection.outlo...
at 06.21, 07.24 and 08.19 Now these structures can be explained as
microbubbles made from polyvinyl alcohol see Fig 2 in: "Controlled
Morphing of Microbubbles to Beaded Nanofibers via Electrically Forced Thin
Film Stretching" by Yao et al Polymers 2017, 9(7), 265 which can be
downloaded at
https://eur01.safelinks.protection.outlo...
1. Will you confirm that microbubbles are present in the J&J COVID-19
vaccine inoculations 2. What is the purpose of these microbubble materials
in the J&J COVID-19 vaccine? 3. What safety and toxicological studies have
been conducted with these microbubble materials? 4. What polymers, nano
particles or other related non-biological structures are present in the
Pfizer BioNTech, Moderna or Oxford/AstraZeneca COVID-19 vaccines? 5. Are
graphene or graphene oxide present in Pfizer BioNTech, Moderna,
Oxford/AstraZeneca or J&J COVID-19 vaccines? Yours faithfully, Graham
Crawley
------------------------------------------------------------------- Please
use this email address for all replies to this request:
[FOI #800251 email] Is [MHRA request email] the wrong
address for Freedom of Information requests to Medicines and Healthcare
Products Regulatory Agency? If so, please contact us using this form:
https://eur01.safelinks.protection.outlo...
Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
https://eur01.safelinks.protection.outlo...
For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
https://eur01.safelinks.protection.outlo...
Please note that in some cases publication of requests and responses will
be delayed. If you find this service useful as an FOI officer, please ask
your web manager to link to us from your organisation's FOI page.

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

1 Attachment

  • Attachment

    RE FOI 21 714 21 715 Freedom of Information request Oxford Astrazeneca vaccine ChAdOx1 S recombinant toxicolgy and pharmacodynamics.txt

    14K Download View as HTML

Dear Mr Crawley

 

Regarding the questions in your request of 16 October 2021, please see
below MHRA’s response.

 

1.  Will you confirm that microbubbles are present in the J&J COVID-19
vaccine inoculations

2.  What is the purpose of these microbubble materials in the J&J COVID-19
vaccine?

3.  What safety and toxicological studies have been conducted with these
microbubble materials?

There are no microbubbles present in this vaccine. Links to the Public
Assessment Reports, Information for Healthcare Professionals/Summary of
Product Characteristics and Information for Recipients of the
Vaccine/Patient Information Leaflet have been sent to you previously that
detail the ingredients in this vaccine and the non-clinical and clinical
studies that have been performed to show that this vaccine is safe.

 

4.  What polymers, nano particles or other related non-biological
structures are present in the Pfizer BioNTech, Moderna or
Oxford/AstraZeneca COVID-19 vaccines?

5.  Are graphene or graphene oxide present in Pfizer BioNTech, Moderna,
Oxford/AstraZeneca or J&J COVID-19 vaccines?

Links to the Public Assessment Reports, Information for Healthcare
Professionals/Summary of Product Characteristics and Information for
Recipients of the Vaccine/Patient Information Leaflet have been sent to
you previously that detail the ingredients in the authorised vaccines.
None of these vaccines contain graphene or graphene oxide.

 

Best regards,

 

MHRA Customer Service Centre

 

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

Telephone 020 3080 6000

 

 

show quoted sections